OPHTHALMIC DEVICES PANEL
OPEN SESSION
January 17, 2002
9:30 A.M. – 5 P.M.
Hilton Washington DC North/Gaithersburg
Salons A, B, and C
620 Perry Parkway
Gaithersburg, MD
9:30 AM Call to Order Jayne S. Weiss, M.D. - Acting Chair
Introductory Remarks Sara M. Thornton - Executive Secretary
Conflict of Interest Statement
Appointment to Temporary Voting Status
______________________________________________________
9:45 - 10:15 OPEN PUBLIC HEARING
_______________________________________________
OPEN COMMITTEE SESSION
Jayne S. Weiss, M.D., Acting Chair
10:15 - 10:30 BRANCH UPDATES
Donna R. Lochner
Chief, Intraocular and Corneal Implants Branch
PMA P010059
10:30 - 11:30 SPONSOR PRESENTATION
11:30 - 11:45 Panel Questions for the Sponsor
11:45 - 12 Noon FDA PRESENTATION
Donna Lochner – Introduction
Joel P. Glover – Team Leader
Bernard L. Lepri, O.D., M.S., M.Ed. - Clinical Reviewer
12 Noon – 12:15 PM Panel Questions for FDA
12:15 - 12:20 Additional Comments From the Sponsor
12:20 - 1:20 LUNCH
1:20 COMMITTEE DELIBERATIONS
Primary Panel Reviewers: Joel Sugar, M.D.
Woodford S. Van Meter, M.D.
PANEL DISCUSSION OF P010059
to include FDA questions to the Panel
30-MINUTE OPEN PUBLIC HEARING SESSION
FDA – CLOSING COMMENTS (5 minutes)
SPONSOR – CLOSING COMMENTS (5 minutes)
Voting Options Read
PANEL RECOMMENDATION TAKEN BY VOTE
POLLING OF PANEL VOTES
COMMENTS FROM CONSUMER AND INDUSTRY REPRESENTATIVES
FINAL PANEL COMMENTS
5:00 PM OPEN MEETING ADJOURNED
NOTE: 15-MIN. BREAKS MAY BE GIVEN AT AN APPROPRIATE TIME DURING THE PROCEEDINGS